{"transactions":[{"id":707517,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-17T21:13:10.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":3399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on July 15, 2027. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 15, 2029. The RSU is vested as to 0 shares on July 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on July 15, 2027. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 15, 2029. The RSU is vested as to 0 shares on July 15, 2026."}],"balance_after":3399,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3399},"source":{"system":"sec-edgar","filing":"0000874015-26-000246","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000246/edgardoc.xml","form_type":"4"}},{"id":747017,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-08T20:59:21.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of 06/04/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 06/04/2027. The option shall be fully vested and  exercisable on 06/04/2029. The stock option was exercisable as to 0 shares on 06/04/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grant of 06/04/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 06/04/2027. The option shall be fully vested and  exercisable on 06/04/2029. The stock option was exercisable as to 0 shares on 06/04/2026."}],"balance_after":10753,"derivative":{"exercise_price":75.13,"exercise_date":"2027-06-04","expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":10753},"source":{"system":"sec-edgar","filing":"0000874015-26-000202","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000202/edgardoc.xml","form_type":"4"}},{"id":811951,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":64.36,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":5535},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811950,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":76.32,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":4536},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811949,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4210,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":78.49,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":4210},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811948,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":70.28,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":5293},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811947,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":71.03,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":5055},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811946,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":47.36,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":7322},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811945,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":46.81,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":6523},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811944,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"For Footnote (4), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"For Footnote (4), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":41.54,"expiration_date":"2028-11-21","underlying":"Common Stock","underlying_shares":2012},"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":811943,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-09T21:06:28.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16146,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 3,695 restricted stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the \"Merger Agreement\"), by and among Hologic, Inc. (\"Hologic\" or \"Company\"), Hopper Parent Inc., a Delaware corporation (\"Parent\"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent.  At the effective time of the Merger (the \"Effective Time\"), each share of Hologic common stock, par value $0.01 (\"Company Common Stock\"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the \"Cash Consideration\") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a \"CVR\") (the consideration contemplated by clauses (x) and (y), together, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each time-vesting restricted stock unit award (a \"Company RSU Award\") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000859737-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000063/form4.xml","form_type":"4"}},{"id":875580,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-02T21:17:47.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":3190,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":16146,"source":{"system":"sec-edgar","filing":"0000859737-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000019/form4.xml","form_type":"4"}},{"id":1239603,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-28T21:18:38.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":5535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options become exercisable on the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":5535,"derivative":{"exercise_price":64.36,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":5535},"source":{"system":"sec-edgar","filing":"0001127602-25-007242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760225007242/form4.xml","form_type":"4"}},{"id":1239602,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-28T21:18:38.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":1864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2026 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":12956,"source":{"system":"sec-edgar","filing":"0001127602-25-007242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760225007242/form4.xml","form_type":"4"}},{"id":1585332,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-11T21:54:04.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":4536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options become exercisable on the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":4536,"derivative":{"exercise_price":76.32,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":4536},"source":{"system":"sec-edgar","filing":"0001127602-24-009440","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760224009440/form4.xml","form_type":"4"}},{"id":1585331,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-11T21:54:04.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":1572,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":11092,"source":{"system":"sec-edgar","filing":"0001127602-24-009440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760224009440/form4.xml","form_type":"4"}},{"id":1957599,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-03-13T20:16:07.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":4210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options become exercisable on the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":4210,"derivative":{"exercise_price":78.49,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":4210},"source":{"system":"sec-edgar","filing":"0001127602-23-009870","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760223009870/form4.xml","form_type":"4"}},{"id":1957598,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T20:16:07.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":1465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units which vest on the date of the 2024 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":9520,"source":{"system":"sec-edgar","filing":"0001127602-23-009870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760223009870/form4.xml","form_type":"4"}},{"id":2336578,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-03-14T20:26:47.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":5293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options become exercisable on the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":5293,"derivative":{"exercise_price":70.28,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":5293},"source":{"system":"sec-edgar","filing":"0001127602-22-009136","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222009136/form4.xml","form_type":"4"}},{"id":2336577,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-14T20:26:47.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":1565,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2023 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":8055,"source":{"system":"sec-edgar","filing":"0001127602-22-009136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222009136/form4.xml","form_type":"4"}},{"id":2626536,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2021-07-23T16:32:28.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":56762,"price":118.83,"value":6745028.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the First Effective Time, these options were cancelled and converted into the right to receive the product obtained by multiplying (A) the excess, if any, of the value of the Merger Consideration over the exercise price per share of the Alexion common stock subject to such options immediately prior to the First Effective Time by (B) the number of shares of Alexion common stock subject to such option immediately prior to the First Effective Time by (ii) the value of the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":118.83,"exercise_date":"2018-03-27","expiration_date":"2027-03-27","underlying":"Common Stock, par value $.0001 per share","underlying_shares":56762},"source":{"system":"sec-edgar","filing":"0000899866-21-000063","document":"wf-form4_162707230143608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000063/wf-form4_162707230143608.xml","form_type":"4"}},{"id":2626535,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:32:28.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":580809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC.  In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\")."}],"balance_after":9098,"source":{"system":"sec-edgar","filing":"0000899866-21-000063","document":"wf-form4_162707230143608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000063/wf-form4_162707230143608.xml","form_type":"4"}},{"id":2632542,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:56:01.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":119847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan."}],"balance_after":589907,"source":{"system":"sec-edgar","filing":"0000899866-21-000058","document":"wf-form4_162646894566541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000058/wf-form4_162646894566541.xml","form_type":"4"}},{"id":2632541,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:56:01.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":120894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan."}],"balance_after":470060,"source":{"system":"sec-edgar","filing":"0000899866-21-000058","document":"wf-form4_162646894566541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000058/wf-form4_162646894566541.xml","form_type":"4"}},{"id":2765213,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-04-01T07:44:22.000Z","date":"2021-03-29","kind":"tax_withholding","acquired":false,"shares":2332,"price":154.03,"value":359197.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":349166,"source":{"system":"sec-edgar","filing":"0000899866-21-000030","document":"wf-form4_161727741953647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000030/wf-form4_161727741953647.xml","form_type":"4"}},{"id":2790308,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-03-15T22:16:51.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":5055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option becomes exercisable on the date of the 2022 Annual Meeting of Stockholders."}],"balance_after":5055,"derivative":{"exercise_price":71.03,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":5055},"source":{"system":"sec-edgar","filing":"0001127602-21-010626","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221010626/form4.xml","form_type":"4"}},{"id":2790307,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-15T22:16:51.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":1478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2022 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,217 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan."}],"balance_after":6490,"source":{"system":"sec-edgar","filing":"0001127602-21-010626","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221010626/form4.xml","form_type":"4"}},{"id":2822836,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-03-02T18:01:17.000Z","date":"2021-02-28","kind":"grant","acquired":true,"shares":83725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":351498,"source":{"system":"sec-edgar","filing":"0000899866-21-000029","document":"wf-form4_161472605260522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000029/wf-form4_161472605260522.xml","form_type":"4"}},{"id":2938561,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:12:16.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":13059,"price":157.96,"value":2062799.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":267773,"source":{"system":"sec-edgar","filing":"0000899866-20-000097","document":"wf-form4_160832951612396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000097/wf-form4_160832951612396.xml","form_type":"4"}},{"id":2938560,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:12:16.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":72533,"price":157.96,"value":11457312.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."}],"balance_after":280832,"source":{"system":"sec-edgar","filing":"0000899866-20-000097","document":"wf-form4_160832951612396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000097/wf-form4_160832951612396.xml","form_type":"4"}},{"id":2938559,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:12:16.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":162707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan."}],"balance_after":353365,"source":{"system":"sec-edgar","filing":"0000899866-20-000097","document":"wf-form4_160832951612396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000097/wf-form4_160832951612396.xml","form_type":"4"}},{"id":3191531,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-31T17:04:22.000Z","date":"2020-03-30","kind":"tax_withholding","acquired":false,"shares":3202,"price":85.43,"value":273546.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":190658,"source":{"system":"sec-edgar","filing":"0000899866-20-000035","document":"wf-form4_158568864459640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000035/wf-form4_158568864459640.xml","form_type":"4"}},{"id":3221455,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-03-09T21:04:38.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":7322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2021 Annual Meeting of Stockholders."}],"balance_after":7322,"derivative":{"exercise_price":47.36,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":7322},"source":{"system":"sec-edgar","filing":"0001127602-20-009972","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220009972/form4.xml","form_type":"4"}},{"id":3221454,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-09T21:04:38.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":2217,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2021 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":5012,"source":{"system":"sec-edgar","filing":"0001127602-20-009972","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220009972/form4.xml","form_type":"4"}},{"id":3234903,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:30:03.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":8406,"price":90.54,"value":761079.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.48 - $92.26.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":193860,"source":{"system":"sec-edgar","filing":"0000899866-20-000025","document":"wf-form4_158327818642994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000025/wf-form4_158327818642994.xml","form_type":"4"}},{"id":3234902,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:30:03.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":44201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":202266,"source":{"system":"sec-edgar","filing":"0000899866-20-000025","document":"wf-form4_158327818642994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000025/wf-form4_158327818642994.xml","form_type":"4"}},{"id":3283189,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-02-10T17:00:02.000Z","date":"2020-02-07","kind":"tax_withholding","acquired":false,"shares":12771,"price":102.97,"value":1315029.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $102.97 - $103.19.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":158065,"source":{"system":"sec-edgar","filing":"0000899866-20-000016","document":"wf-form4_158137198557055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000016/wf-form4_158137198557055.xml","form_type":"4"}},{"id":3603154,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-03-11T20:31:06.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":6523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2020 Annual Meeting of Stockholders"}],"balance_after":6523,"derivative":{"exercise_price":46.81,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":6523},"source":{"system":"sec-edgar","filing":"0001127602-19-010811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219010811/form4.xml","form_type":"4"}},{"id":3603153,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-11T20:31:06.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":2136,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2020 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":2795,"source":{"system":"sec-edgar","filing":"0001127602-19-010811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219010811/form4.xml","form_type":"4"}},{"id":3615638,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-05T20:24:43.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":37198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":170836,"source":{"system":"sec-edgar","filing":"0000899866-19-000052","document":"wf-form4_155183546915912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000052/wf-form4_155183546915912.xml","form_type":"4"}},{"id":3620731,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-04T17:39:28.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":4043,"price":132.92,"value":537395.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $134.70.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":133638,"source":{"system":"sec-edgar","filing":"0000899866-19-000039","document":"wf-form4_155173914470163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000039/wf-form4_155173914470163.xml","form_type":"4"}},{"id":3666576,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-02-11T18:39:23.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":13015,"price":119.57,"value":1556203.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $119.42 - $119.57.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":137681,"source":{"system":"sec-edgar","filing":"0000899866-19-000016","document":"wf-form4_154992834912908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000016/wf-form4_154992834912908.xml","form_type":"4"}},{"id":3710745,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-01-03T18:07:35.000Z","date":"2018-12-31","kind":"sale","acquired":false,"shares":3244,"price":95.85,"value":310937.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $95.84 - $96.49.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":150696,"source":{"system":"sec-edgar","filing":"0000899866-19-000005","document":"wf-form4_154655683354052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000005/wf-form4_154655683354052.xml","form_type":"4"}},{"id":3753306,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-11-26T21:15:50.000Z","date":"2018-11-21","kind":"grant","acquired":true,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2019 Annual Meeting of Stockholders."}],"balance_after":2012,"derivative":{"exercise_price":41.54,"expiration_date":"2028-11-21","underlying":"Common Stock","underlying_shares":2012},"source":{"system":"sec-edgar","filing":"0001127602-18-034295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760218034295/form4.xml","form_type":"4"}},{"id":3753305,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-26T21:15:50.000Z","date":"2018-11-21","kind":"grant","acquired":true,"shares":659,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2019 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":659,"source":{"system":"sec-edgar","filing":"0001127602-18-034295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760218034295/form4.xml","form_type":"4"}},{"id":4021789,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-02T17:01:35.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":35760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":153940,"source":{"system":"sec-edgar","filing":"0000899866-18-000061","document":"wf-form4_152002808052042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000061/wf-form4_152002808052042.xml","form_type":"4"}},{"id":4071040,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:07.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":13245,"price":116.31,"value":1540525.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":118180,"source":{"system":"sec-edgar","filing":"0000899866-18-000036","document":"wf-form4_151813535338397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000036/wf-form4_151813535338397.xml","form_type":"4"}},{"id":4071039,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:07.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":95253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 95,253 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary."}],"balance_after":131425,"source":{"system":"sec-edgar","filing":"0000899866-18-000036","document":"wf-form4_151813535338397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000036/wf-form4_151813535338397.xml","form_type":"4"}},{"id":4108869,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-01-04T18:33:33.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":2553,"price":121.63,"value":310521.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $121.00 - $121.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":36172,"source":{"system":"sec-edgar","filing":"0000899866-18-000002","document":"wf-form4_151510879943504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000002/wf-form4_151510879943504.xml","form_type":"4"}},{"id":4278114,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-06-19T17:21:10.000Z","date":"2017-06-14","kind":"purchase","acquired":true,"shares":10000,"price":116.72,"value":1167200.0,"ownership":{"direct":true},"balance_after":38725,"source":{"system":"sec-edgar","filing":"0000899866-17-000144","document":"wf-form4_149790725629978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000144/wf-form4_149790725629978.xml","form_type":"4"}},{"id":4369696,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-29T18:13:57.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":56762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock option award under 2004 Incentive Plan.  Vests 25% on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years."}],"balance_after":56762,"derivative":{"exercise_price":118.83,"exercise_date":"2018-03-27","expiration_date":"2027-03-27","underlying":"Common Stock, par value $.0001 per share","underlying_shares":56762},"source":{"system":"sec-edgar","filing":"0000899866-17-000076","document":"wf-form4_149082562233246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000076/wf-form4_149082562233246.xml","form_type":"4"}},{"id":4369695,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29928,"kind":"person","name":"HANTSON LUDWIG","position":1,"cik":"0001491435","reported_name":"HANTSON LUDWIG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-29T18:13:57.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":28725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2004 Incentive Plan.  Vests 25% on each of December 31, 2017, December 31, 2018, March 27, 2020, and March 27, 2021."}],"balance_after":57450,"source":{"system":"sec-edgar","filing":"0000899866-17-000076","document":"wf-form4_149082562233246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000076/wf-form4_149082562233246.xml","form_type":"4"}}]}